Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
March-2023 Volume 25 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2023 Volume 25 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review

  • Authors:
    • Dragoş Puia
    • Ştefan Gheorghincă
    • George Daniel Radavoi
    • Viorel Jinga
    • Cătălin Pricop
  • View Affiliations / Copyright

    Affiliations: Department of Urology, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iași, Romania, Department of Urology, Neamţ Emergency County Hospital, 610136 Piatra Neamt, Romania, Department of Urology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
    Copyright: © Puia et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 110
    |
    Published online on: January 25, 2023
       https://doi.org/10.3892/etm.2023.11809
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

With the increase in percutaneous interventions such as percutaneous nephrolithotomy (PCNL) for renal lithiasis, infectious complications are becoming more frequent. The present study performed a systematic Medline and Embase databases search, using the following words: ‘PCNL’ [MeSH Terms] AND [‘sepsis’ (All Fields) OR ‘PCNL’ (All Fields)] AND [‘septic shock’ (All Fields)] AND [‘urosepsis’ (MeSH Terms) OR ‘Systemic inflammatory response syndrome (SIRS)’ (All Fields)]. Because of the technological advances in endourology, articles published between 2012 and 2022 were searched. Of the 1,403 results of the search, only 18 articles, representing 7,507 patients in which PCNL was performed, met the criteria to be included in the analysis. All authors applied antibiotic prophylaxis to all patients and, in some cases, the infection was treated preoperatively in those with positive urine cultures. According to the analysis of the present study, the operative time has been significantly longer in patients who developed SIRS/sepsis post‑operatively (P=0.0001) with the highest heterogeneity (I2=91%) compared with other factors. Patients with a positive preoperative urine culture had a significantly higher risk of developing SIRS/sepsis following PCNL (P=0.00001), OD=2.92 (1.82, 4.68) and there was also a high degree of heterogeneity (I2=80%). Performing a multi‑tract PCNL also increased the incidence of postoperative SIRS/sepsis (P=0.00001), OD=2.64 (1.78, 3.93) and the heterogeneity was a little smaller (I2=67%). Diabetes mellitus (P=0.004), OD=1.50 (1.14, 1.98), I2=27% and preoperative pyuria (P=0.002), OD=1.75 (1.23, 2.49), I2=20%, were other factors that significantly influenced postoperative evolution. A total of two factors analyzed, body mass index and patient's age, did not influence the outcome, P=0.45, I2=58% and P=0.98, I2=63%.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Yu J, Guo B, Yu J, Chen T, Han X, Niu Q, Xu S, Guo Z, Shi Q, Peng X, et al: Antibiotic prophylaxis in perioperative period of percutaneous nephrolithotomy: A systematic review and meta-analysis of comparative studies. World J Urol. 38:1685–1700. 2020.PubMed/NCBI View Article : Google Scholar

2 

Jiang Y and Zhang J, Kang N, Niu Y, Li Z, Yu C and Zhang J: Current Trends in percutaneous nephrolithotomy in China: A spot survey. Risk Manag Health Policy. 14:2507–2515. 2021.PubMed/NCBI View Article : Google Scholar

3 

Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M and Knoll T: EAU guidelines on interventional treatment for urolithiasis. Eur Urol. 69:475–482. 2016.PubMed/NCBI View Article : Google Scholar

4 

Sharma K, Sankhwar SN, Goel A, Singh V, Sharma P and Garg Y: Factors predicting infectious complications following percutaneous nephrolithotomy. Urol Ann. 8:434–438. 2016.PubMed/NCBI View Article : Google Scholar

5 

Michel MS, Trojan L and Rassweiler JJ: Complications in percutaneous nephrolithotomy. Eur Urol. 51:899–906. 2007.PubMed/NCBI View Article : Google Scholar

6 

Yang Z, Lin D, Hong Y, Hu M, Cai W, Pan H, Li Q, Lin J and Ye L: The effect of preoperative urine culture and bacterial species on infection after percutaneous nephrolithotomy for patients with upper urinary tract stones. Sci Rep. 12(4833)2022.PubMed/NCBI View Article : Google Scholar

7 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View Article : Google Scholar

8 

Amier Y, Zhang Y, Zhang J, Yao W, Wang S, Wei C and Yu X: Analysis of preoperative risk factors for postoperative urosepsis after mini-percutaneous nephrolithotomy in patients with large kidney stones. J Endourol. 36:292–297. 2022.PubMed/NCBI View Article : Google Scholar

9 

Chen D, Jiang C, Liang X, Zhong F, Huang J, Lin Y, Zhao Z, Duan X, Zeng G and Wu W: Early and rapid prediction of postoperative infections following percutaneous nephrolithotomy in patients with complex kidney stones. BJU Int. 123:1041–1047. 2019.PubMed/NCBI View Article : Google Scholar

10 

Chhetri RK, Baral S and Thapa N: Prediction of infectious complications after percutaneous nephrolithotomy. J Soc Surg Nepal. 21:12–18. 2018.

11 

He Z, Tang F, Lei H, Chen Y and Zeng G: Risk factors for systemic inflammatory response syndrome after percutaneous nephrolithotomy. Prog Urol. 28:582–587. 2018.PubMed/NCBI View Article : Google Scholar

12 

Koras O, Bozkurt IH, Yonguc T, Degirmenci T, Arslan B, Gunlusoy B, Aydogdu O and Minareci S: Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: A prospective clinical study. Urolithiasis. 43:55–60. 2015.PubMed/NCBI View Article : Google Scholar

13 

Kumar GC, Devraj R, Sagar V, Chandraiah R, Prasad D and Ch R: Factors determining postoperative infectious complications of percutaneous nephrolithotomy: Experience from a single center. Int J Health Clin Res. 4:127–130. 2021.

14 

Liu J, Zhou C, Gao W, Huang H, Jiang X and Zhang D: Does preoperative urine culture still play a role in predicting post-PCNL SIRS? A retrospective cohort study. Urolithiasis. 48:251–256. 2020.PubMed/NCBI View Article : Google Scholar

15 

Liu J, Yang Q, Lan J, Hong Y, Huang X and Yang B: Risk factors and prediction model of urosepsis in patients with diabetes after percutaneous nephrolithotomy. BMC Urol. 21(74)2021.PubMed/NCBI View Article : Google Scholar

16 

Lorenzo Soriano L, Ordaz Jurado DG, Pérez Ardavín J, Budía Alba A, Bahílo Mateu P, Trassierra Villa M and López Acón D: Predictive factors of infectious complications in the postoperative of percutaneous nephrolithotomy. Actas Urol Esp (Engl Ed). 43:131–136. 2019.PubMed/NCBI View Article : Google Scholar

17 

Rashid AO and Fakhulddin SS: Risk factors for fever and sepsis after percutaneous nephrolithotomy. Asian J Urol. 3:82–87. 2016.PubMed/NCBI View Article : Google Scholar

18 

Tabei T, Ito H, Usui K, Kuroda S, Kawahara T, Terao H, Fujikawa A, Makiyama K, Yao M and Matsuzaki J: Risk factors of systemic inflammation response syndrome after endoscopic combined intrarenal surgery in the modified Valdivia position. Int J Urol. 23:687–692. 2016.PubMed/NCBI View Article : Google Scholar

19 

Tang Y, Zhang C, Mo C, Gui C, Luo J and Wu R: Predictive model for systemic infection after percutaneous nephrolithotomy and related factors analysis. Front Surg. 8(696463)2021.PubMed/NCBI View Article : Google Scholar

20 

Teh KY and Tham TM: Predictors of post-percutaneous nephrolithotomy sepsis: The Northern Malaysian experience. Urol Ann. 13:156–162. 2021.PubMed/NCBI View Article : Google Scholar

21 

Wang S, Yuan P, Peng E, Xia D, Xu H, Wang S, Ye Z and Chen Z: Risk factors for urosepsis after minimally invasive percutaneous nephrolithotomy in patients with preoperative urinary tract infection. Biomed Res Int. 2020(1354672)2020.PubMed/NCBI View Article : Google Scholar

22 

Wei W, Leng J, Shao H and Wang W: Diabetes, a risk factor for both infectious and major complications after percutaneous nephrolithotomy. Int J Clin Exp Med. 8:16620–16626. 2015.PubMed/NCBI

23 

Xu P, Zhang S, Zhang Y, Zeng T, Chen D and Wu W, Tiselius HG, Li S, Huang J, Zeng G and Wu W: Preoperative antibiotic therapy exceeding 7 days can minimize infectious complications after percutaneous nephrolithotomy in patients with positive urine culture. World J Urol. 40:193–199. 2022.PubMed/NCBI View Article : Google Scholar

24 

Yang T, Liu S, Hu J, Wang L and Jiang H: The evaluation of risk factors for postoperative infectious complications after percutaneous nephrolithotomy. Biomed Res Int. 2017(4832051)2017.PubMed/NCBI View Article : Google Scholar

25 

Zhu Z, Cui Y, Zeng H, Li Y, Zeng F, Li Y, Chen Z and Hequn C: The evaluation of early predictive factors for urosepsis in patients with negative preoperative urine culture following mini-percutaneous nephrolithotomy. World J Urol. 38:2629–2636. 2020.PubMed/NCBI View Article : Google Scholar

26 

Ghani KR, Sammon JD, Bhojani N, Karakiewicz PI, Sun M, Sukumar S, Littleton R, Peabody JO, Menon M and Trinh QD: Trends in percutaneous nephrolithotomy use and outcomes in the United States. J Urol. 190:558–564. 2013.PubMed/NCBI View Article : Google Scholar

27 

Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, Ligotti ME, Zareian N and Accardi G: Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. 10(2247)2019.PubMed/NCBI View Article : Google Scholar

28 

Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH and Moulton VR: Aging, immunity, and COVID-19: How age influences the host immune response to coronavirus infections? Front Physiol. 11(571416)2021.PubMed/NCBI View Article : Google Scholar

29 

Zhou YY and Sun BW: Recent advances in neutrophil chemotaxis abnormalities during sepsis. Chin J Traumatol. 25:317–324. 2022.PubMed/NCBI View Article : Google Scholar

30 

Hao Z, Wang J, Wang Q, Luan G and Qian B: Preoperative risk factors associated with urosepsis following percutaneous nephrolithotomy: A meta-analys. Int J Clin Exp Med. 12:9616–9628. 2019.

31 

Dogan HS, Guliyev F, Cetinkaya YS, Sofikerim M, Ozden E and Sahin A: Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol. 39:737–742. 2007.PubMed/NCBI View Article : Google Scholar

32 

Walton-Diaz A, Vinay JI, Barahona J, Daels P, González M, Hidalgo JP, Palma C, Díaz P, Domenech A, Valenzuela R and Marchant F: Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis-a non-randomized prospective observation cohort study. Int Urol Nephrol. 49:31–35. 2017.PubMed/NCBI View Article : Google Scholar

33 

Aghdas FS, Akhavizadegan H, Aryanpoor A, Inanloo H and Karbakhsh M: Fever after percutaneous nephrolithotomy: Contributing factors. Surg Infect (Larchmt). 7:367–371. 2006.PubMed/NCBI View Article : Google Scholar

34 

Benson AD, Juliano TM and Miller NL: Infectious outcomes of nephrostomy drainage before percutaneous nephrolithotomy compared to concurrent access. J Urol. 192:770–774. 2014.PubMed/NCBI View Article : Google Scholar

35 

Verma A, Bhani D, Tomar V, Bachhiwal R and Yadav S: Differences in bacterial colonization and biofilm formation property of uropathogens between the two most commonly used indwelling urinary catheters. J Clin Diagn Res. 10:PC01–PC03. 2016.PubMed/NCBI View Article : Google Scholar

36 

Poore W, Boyd CJ, Singh NP, Wood K, Gower B and Assimos DG: Obesity and its impact on kidney stone formation. Rev Urol. 22:17–23. 2020.PubMed/NCBI

37 

Taylor EN, Stampfer MJ and Curhan GC: Obesity, weight gain, and the risk of kidney stones. JAMA. 293:455–462. 2005.PubMed/NCBI View Article : Google Scholar

38 

Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM and Preminger GM: Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 172:159–163. 2004.PubMed/NCBI View Article : Google Scholar

39 

Semins MJ, Shore AD, Makary MA, Weiner J and Matlaga BR: The impact of obesity on urinary tract infection risk. Urology. 79:266–269. 2012.PubMed/NCBI View Article : Google Scholar

40 

Torrecilla Ortiz C, Meza Martínez AI, Vicens Morton AJ, Vila Reyes H, Colom Feixas S, Suarez Novo JF and Franco Miranda E: Obesity in percutaneous nephrolithotomy. Is body mass index really important? Urology. 84:538–543. 2014.PubMed/NCBI View Article : Google Scholar

41 

Domingos F and Serra A: Metabolic syndrome: A multifaceted risk factor for kidney stones. Scand J Urol. 48:414–419. 2014.PubMed/NCBI View Article : Google Scholar

42 

Chiu PF, Huang CH, Liou HH, Wu CL, Wang SC and Chang CC: Long-term renal outcomes of episodic urinary tract infection in diabetic patients. J Diabetes Complications. 27:41–43. 2013.PubMed/NCBI View Article : Google Scholar

43 

Murtha MJ, Eichler T, Bender K, Metheny J, Li B, Schwaderer AL, Mosquera C, James C, Schwartz L, Becknell B and Spencer JD: Insulin receptor signaling regulates renal collecting duct and intercalated cell antibacterial defenses. J Clin Invest. 128:5634–5646. 2018.PubMed/NCBI View Article : Google Scholar

44 

Giubilato S, Liuzzo G, Brugaletta S, Pitocco D, Graziani F, Smaldone C, Montone RA, Pazzano V, Pedicino D, Biasucci LM, et al: Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J. 32:1214–1226. 2011.PubMed/NCBI View Article : Google Scholar

45 

Geerlings SE and Hoepelman AI: Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 26:259–265. 1999.PubMed/NCBI View Article : Google Scholar

46 

Liang T, Zhao C, Wu G, Tang B, Luo X, Lu S, Dong Y and Yang H: Multi-tract percutaneous nephrolithotomy combined with EMS lithotripsy for bilateral complex renal stones: Our experience. BMC Urol. 17(15)2017.PubMed/NCBI View Article : Google Scholar

47 

Rashid AO, Mahmood SN, Amin AK, Bapir R and Buchholz N: Multitract percutaneous nephrolithotomy in the management of staghorn stones. Afr J Urol. 26(74)2020.

48 

Desai M, Jain P, Ganpule A, Sabnis R, Patel S and Shrivastav P: Developments in technique and technology: The effect on the results of percutaneous nephrolithotomy for staghorn calculi. BJU Int. 104:542–548. 2009.PubMed/NCBI View Article : Google Scholar

49 

Schnabel MJ, Rosenhammer B, Steckermeier M, Fritsche HM, Burger M and Spachmann PJ: Miniaturized percutaneous nephrolithotomy without antibiotic prophylaxis: A single institution experience. Int Urol Nephrol. 53:1551–1556. 2021.PubMed/NCBI View Article : Google Scholar

50 

Xu P, Zhang S, Zhang Y, Zeng T, Chen D and Wu W, Tiselius HG, Li S, Huang J, Zeng G and Wu W: Enhanced antibiotic treatment based on positive urine dipstick infection test before percutaneous nephrolithotomy did not prevent postoperative infection in patients with negative urine culture. J Endourol. 35:1743–1749. 2021.PubMed/NCBI View Article : Google Scholar

51 

European Association of Urology (EAU): Guideline on urolithiasis. EAU, Arnhem, 2022. https://uroweb.org/guidelines/urolithiasis. Accessed December 20, 2022.

52 

Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM, et al: Medical management of kidney stones: AUA guideline. J Urol. 192:316–324. 2014.PubMed/NCBI View Article : Google Scholar

53 

Zhang S, Li G, Qiao L, Lai D, He Z, An L, Xu P, Tiselius HG, Zeng G, Zheng J and Wu W: The antibiotic strategies during percutaneous nephrolithotomy in China revealed the gap between the reality and the urological guidelines. BMC Urol. 22(136)2022.PubMed/NCBI View Article : Google Scholar

54 

He C, Chen H, Li Y, Zeng F, Cui Y and Chen Z: Antibiotic administration for negative midstream urine culture patients before percutaneous nephrolithotomy. Urolithiasis. 49:505–512. 2021.PubMed/NCBI View Article : Google Scholar

55 

Puia D, Radavoi GD, Proca TM, Puia A, Jinga V and Pricop C: Urinary tract infections in complicated kidney stones: Can they be correlated with Guy's stone score? J Pak Med Assoc. 72:1721–1725. 2022.PubMed/NCBI View Article : Google Scholar

56 

Akman T, Binbay M, Akcay M, Tekinarslan E, Kezer C, Ozgor F, Seyrek M and Muslumanoglu AY: Variables that influence operative time during percutaneous nephrolithotomy: An analysis of 1897 cases. J Endourol. 25:1269–1273. 2011.PubMed/NCBI View Article : Google Scholar

57 

Jiao B, Luo Z, Huang T, Zhang G and Yu J: A systematic review and meta-analysis of minimally invasive vs standard percutaneous nephrolithotomy in the surgical management of renal stones. Exp Ther Med. 21(213)2021.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Puia D, Gheorghincă Ş, Radavoi GD, Jinga V and Pricop C: Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review. Exp Ther Med 25: 110, 2023.
APA
Puia, D., Gheorghincă, Ş., Radavoi, G.D., Jinga, V., & Pricop, C. (2023). Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review. Experimental and Therapeutic Medicine, 25, 110. https://doi.org/10.3892/etm.2023.11809
MLA
Puia, D., Gheorghincă, Ş., Radavoi, G. D., Jinga, V., Pricop, C."Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review". Experimental and Therapeutic Medicine 25.3 (2023): 110.
Chicago
Puia, D., Gheorghincă, Ş., Radavoi, G. D., Jinga, V., Pricop, C."Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review". Experimental and Therapeutic Medicine 25, no. 3 (2023): 110. https://doi.org/10.3892/etm.2023.11809
Copy and paste a formatted citation
x
Spandidos Publications style
Puia D, Gheorghincă Ş, Radavoi GD, Jinga V and Pricop C: Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review. Exp Ther Med 25: 110, 2023.
APA
Puia, D., Gheorghincă, Ş., Radavoi, G.D., Jinga, V., & Pricop, C. (2023). Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review. Experimental and Therapeutic Medicine, 25, 110. https://doi.org/10.3892/etm.2023.11809
MLA
Puia, D., Gheorghincă, Ş., Radavoi, G. D., Jinga, V., Pricop, C."Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review". Experimental and Therapeutic Medicine 25.3 (2023): 110.
Chicago
Puia, D., Gheorghincă, Ş., Radavoi, G. D., Jinga, V., Pricop, C."Can we identify the risk factors for SIRS/sepsis after percutaneous nephrolithotomy? A meta‑analysis and literature review". Experimental and Therapeutic Medicine 25, no. 3 (2023): 110. https://doi.org/10.3892/etm.2023.11809
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team